Use of Botulinum Toxin Type A in a Patient With Refractory Itch From Notalgia Paresthetica
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Journal of clinical neuromuscular disease - 21(2020), 4 vom: 01. Juni, Seite 243-244 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Datta, Sorabh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Botulinum Toxins, Type A |
|---|
| Anmerkungen: |
Date Completed 26.04.2021 Date Revised 26.04.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1097/CND.0000000000000276 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310352118 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310352118 | ||
| 003 | DE-627 | ||
| 005 | 20231225135916.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/CND.0000000000000276 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1034.xml |
| 035 | |a (DE-627)NLM310352118 | ||
| 035 | |a (NLM)32453101 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Datta, Sorabh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Use of Botulinum Toxin Type A in a Patient With Refractory Itch From Notalgia Paresthetica |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.04.2021 | ||
| 500 | |a Date Revised 26.04.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Neuromuscular Agents |2 NLM | |
| 650 | 7 | |a Botulinum Toxins, Type A |2 NLM | |
| 650 | 7 | |a EC 3.4.24.69 |2 NLM | |
| 700 | 1 | |a Mahal, Shanan |e verfasserin |4 aut | |
| 700 | 1 | |a Bhagavan, Sachin M |e verfasserin |4 aut | |
| 700 | 1 | |a Govindarajan, Raghav |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical neuromuscular disease |d 1999 |g 21(2020), 4 vom: 01. Juni, Seite 243-244 |w (DE-627)NLM174891172 |x 1537-1611 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2020 |g number:4 |g day:01 |g month:06 |g pages:243-244 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/CND.0000000000000276 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2020 |e 4 |b 01 |c 06 |h 243-244 | ||